The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer
Open accessAbstract
Estrogen stimulates the proliferation of the most common type of human breast cancer that expresses estrogen receptor α (ERα) through the activation of the cyclin D1 (CCND1) oncogene. However, our knowledge of ERα transcriptional mechanisms remains limited. Hence, it is still elusive why ERα ectopically expressed in ER-negative breast cancer cells (BCC) is functional on ectopic reporter constructs but lacks activity on many endogenous target genes, including CCND1. Here, we show that estradiol (E2) stimulation of CCND1 expression in BCC depends on a novel cell-type-specific enhancer downstream from the CCND1 coding region, which is the primary ERα recruitment site in estrogen-responsive cells. The pioneer factor FoxA1 is specifically required for the active chromatin state of this enhancer and as such is crucial for both CCND1 expression and subsequent cell cycle progression. Interestingly, even in BCC, CCND1 levels and proliferation are tightly controlled by E2 through the establishment of a negative feedforward loop involving the induction of NFIC, a putative tumor suppressor capable of directly repressing CCND1 transcription. Taken together, our results reveal an estrogen-regulated combinatorial network including cell-specific cis- and trans-regulators of CCND1 expression where ERα collaborates with other transcription factors associated with the ER-positive breast cancer phenotype, including FoxA1 and NFIC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Multiclass cancer diagnosis using tumor gene expression signatures
Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C.-H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J. P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211566398 · Cited by 2,023
Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription
Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., & Brown, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00188-4 · Cited by 1,657
Self-citationLarge-scale analysis of the human and mouse transcriptomes
Su, A. I., Cooke, M. P., Ching, K. A., Hakak, Y., Walker, J. R., Wiltshire, T., Orth, A. P., Vega, R. G., Sapinoso, L. M., Moqrich, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012025199 · Cited by 1,466
Métivier, R., Penot, G., Hübner, M. R., Reid, G., Brand, H., Koš, M., & Gannon, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00934-6 · Cited by 1,431
Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.008 · Cited by 1,384
Self-citationNUCLEASE HYPERSENSITIVE SITES IN CHROMATIN
Gross, D. S., & Garrard, W. T. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001111 · Cited by 1,233
The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling
Hall, J. M., Couse, J. F., & Korach, K. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100029200 · Cited by 1,208
Opening of Compacted Chromatin by Early Developmental Transcription Factors HNF3 (FoxA) and GATA-4
Cirillo, L. A., Lin, F. R., Cuesta, I., Friedman, D., Jarnik, M., & Zaret, K. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00459-8 · Cited by 1,185
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar-Sagi, D., Roussel, M. F., & Sherr, C. J. (1993) · Genes & Development · doi:10.1101/gad.7.8.1559 · Cited by 1,032
Cyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Estrogen receptor pathways to AP-1
Kushner, P. J., Agard, D. A., Greene, G. L., Scanlan, T. S., Shiau, A. K., Uht, R. M., & Webb, P. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00108-4 · Cited by 870
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691
Roles of the NFI/CTF gene family in transcription and development
Gronostajski, R. M. (2000) · Gene · doi:10.1016/s0378-1119(00)00140-2 · Cited by 553
Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression
Liu, M.-M., Albanese, C., Anderson, C. M., Hilty, K., Webb, P., Uht, R. M., Price, R. H., Pestell, R. G., & Kushner, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201829200 · Cited by 422
Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions
Safe, S. (2001) · Vitamins & Hormones · doi:10.1016/s0083-6729(01)62006-5 · Cited by 418
Cyclin D1 in Breast Cancer Pathogenesis
Arnold, A., & Papanikolaou, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.064 · Cited by 411
Musgrove, E. A., Lee, C. S., Buckley, M. F., & Sutherland, R. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8022 · Cited by 376
Laganière, J., Deblois, G., Lefebvre, C., Bataille, A. R., Robert, F., & Giguère, V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505575102 · Cited by 367
Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element
Sabbah, M., Courilleau, D., Mester, J., & Redeuilh, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11217 · Cited by 365
Altucci, L., Addeo, R., Cicatiello, L., Dauvois, S., Parker, M., Truss, M., Beato, M., Sica, V., Bresciani, F., & Weisz, A. (1996) · PubMed · Cited by 343
Transcriptional enhancers: Intelligent enhanceosomes or flexible billboards?
Arnosti, D. N., & Kulkarni, M. M. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20352 · Cited by 309
Musgrove, E. A., Hamilton, J. A., Lee, C. S., Sweeney, K. J., Watts, C. K., & Sutherland, R. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3577 · Cited by 297
c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry
Prall, O. W. J., Rogan, E. M., Musgrove, E. A., Watts, C. K. W., & Sutherland, R. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4499 · Cited by 267
Castro-Rivera, E., Samudio, I., & Safe, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103339200 · Cited by 211
Park, K.-J., Krishnan, V., O’Malley, B. W., Yamamoto, Y., & Gaynor, R. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.006 · Cited by 193
Androgen-induced recruitment of RNA polymerase II to a nuclear receptor–p160 coactivator complex
Louie, M. C., Yang, H. Q., Ma, A., Xu, W., Zou, J. X., Kung, H.-J., & Chen, H.-W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437824100 · Cited by 183
Stoner, M. A., Wormke, M., Saville, B., Samudio, I. J., Qin, C., Abdelrahim, M., & Safe, S. H. (2003) · Oncogene · doi:10.1038/sj.onc.1207201 · Cited by 170
Cicatiello, L., Addeo, R., Sasso, A., Altucci, L., Petrizzi, V. B., Borgo, R., Cancemi, M., Caporali, S., Caristi, S., Scafoglio, C., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7260-7274.2004 · Cited by 164
Lacroix, M., & Leclercq, G. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.02.021 · Cited by 155
Dupont, J., Karas, M., & LeRoith, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006741200 · Cited by 155
The activities of cyclin D1 that drive tumorigenesis
Ewen, M. E., & Lamb, J. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.02.005 · Cited by 148
High-throughput localization of functional elements by quantitative chromatin profiling
Dorschner, M. O., Hawrylycz, M., Humbert, R., Wallace, J. C., Shafer, A., Kawamoto, J., Mack, J., Hall, R., Goldy, J., Sabo, P. J., et al. (2004) · Nature Methods · doi:10.1038/nmeth721 · Cited by 145
Stable ‘portrait’ of breast tumors during progression: data from biology, pathology and genetics
Lacroix, M., Toillon, R., & Leclercq, G. (2004) · Endocrine Related Cancer · doi:10.1677/erc.1.00758 · Cited by 137
Marino, M., Acconcia, F., Bresciani, F., Weisz, A., & Trentalance, A. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-03-0153 · Cited by 135
Hodges-Gallagher, L., Cook, J., Lobenhofer, E. K., Li, L., Bennett, L., Bushel, P. R., Aldaz, C. M., Afshari, C. A., & Walker, C. L. (2003) · PubMed · Cited by 133
Keeton, E. K., & Brown, M. A. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0395 · Cited by 124
Self-citationWilcken, N. R. C., Prall, O. W. J., Musgrove, E. A., & Sutherland, R. L. (1997) · PubMed · Cited by 118
Transcriptional complexes engaged by apo‐estrogen receptor‐α isoforms have divergent outcomes
Métivier, R., Penot, G., Carmouche, R. P., Hübner, M. R., Reid, G., Denger, S., Manu, D., Brand, H., Koš, M., Beneš, V., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600377 · Cited by 117
Estrogen and Progestin Regulation of Cell Cycle Progression
Sutherland, R. L., Prall, O. W. J., Watts, C. K. W., & Musgrove, E. A. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018774302092 · Cited by 116
Eukaryotic transcriptional regulatory complexes: cooperativity from near and afar
Ogata, K., Sato, K., & Tahirov, T. H. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(03)00012-5 · Cited by 104
McArthur, M., Gerum, S. E., & Stamatoyannopoulos, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4969 · Cited by 97
Rubio, M. F., Werbajh, S., Cafferata, E. G. A., Quaglino, A., Coló, G. P., Nojek, I. M., Kordon, E. C., Nahmod, V. E., & Costas, M. A. (2005) · Oncogene · doi:10.1038/sj.onc.1209176 · Cited by 95
Grillo, M., Bott, M. J., Khandke, N., McGinnis, J. P., Miranda, M., Meyyappan, M., Rosfjord, E. C., & Rabindran, S. K. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9066-y · Cited by 89
Xie, W., Duan, R., & Safe, S. H. (1999) · Endocrinology · doi:10.1210/endo.140.1.6394 · Cited by 88
Williamson, E. A., Wolf, I., O’Kelly, J., Bose, S., Tanosaki, S., & Koeffler, H. P. (2005) · Oncogene · doi:10.1038/sj.onc.1209170 · Cited by 79
Kim, K., Barhoumi, R., Burghardt, R. C., & Safe, S. H. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0326 · Cited by 77
Hepatocyte Nuclear Factor 3 Relieves Chromatin-mediated Repression of the α-Fetoprotein Gene
Crowe, A. J., Sang, L., Li, K. K., Lee, K. C., Spear, B. T., & Barton, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.25113 · Cited by 67
The Nuclear Factor I (NFI) Gene Family in Mammary Gland Development and Function
Murtagh, J., Martin, F., & Gronostajski, R. M. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025909109843 · Cited by 57
FoxA1 binding to the MMTV LTR modulates chromatin structure and transcription.
Holmqvist, P.-H., Belikov, S., Zaret, K., & Wrange, O. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.12.002 · Cited by 47
Nuclear factor I interferes with transformation induced by nuclear oncogenes.
Schuur, E. R., Kruse, U., Iacovoni, J. S., & Vogt, P. K. (1995) · PubMed · Cited by 41
Eto, I. (2000) · Cell Proliferation · doi:10.1046/j.1365-2184.2000.00176.x · Cited by 40
Xie, W. (1999) · Endocrinology · doi:10.1210/en.140.1.219 · Cited by 33
Tan, Y., Costa, R. H., Kovesdi, I., & Reichel, R. R. (2001) · Gene Expression · doi:10.3727/000000001783992542 · Cited by 28
Chang, W., Parra, M. P., & McCarthy, T. L. (2005) · Gene · doi:10.1016/j.gene.2004.11.017 · Cited by 24
The Regulation of Cyclin D1 Expression in Senescent Human Fibroblasts
Fukami‐Kobayashi, J., & Mitsui, Y. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4079 · Cited by 24
Long, L.-Y., & Spear, B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9601-9609.2004 · Cited by 21
Cited by
Pioneer transcription factors: establishing competence for gene expression
Zaret, K. S., & Carroll, J. S. (2011) · Genes & Development · doi:10.1101/gad.176826.111 · Cited by 1,589
Self-citationThe emerging roles of forkhead box (Fox) proteins in cancer
Myatt, S. S., & Lam, E. W. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2223 · Cited by 1,070
FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription
Lupien, M., Eeckhoute, J., Meyer, C. A., Wang, Q., Zhang, Y., Li, W., Carroll, J. S., Liu, X. S., & Brown, M. (2008) · Cell · doi:10.1016/j.cell.2008.01.018 · Cited by 983
Self-citationFOXA1 is a key determinant of estrogen receptor function and endocrine response
Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D., & Carroll, J. S. (2011) · Nature Genetics · doi:10.1038/ng.730 · Cited by 844
Self-citationSherwood, R. I., Hashimoto, T., O'Donnell, C. W., Lewis, S., Barkal, A. A., van Hoff, J. P., Karun, V., Jaakkola, T., & Gifford, D. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2798 · Cited by 426
Metadata
- Authors
- Eeckhoute, J., Carroll, J. S., Geistlinger, T. R., Torres-Arzayus, M. I., & Brown, M.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2006-09-15
- Volume
- 20
- Issue
- 18
- Pages
- 2513-2526
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2129036353
- Cited by
- 304
- References
- 60
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.